Adapting their reproductive physiology is a tactic that insects use in responding to conditions of food unavailability. The present study examined the potential effects of starvation periods on the ovarian development and reproduction of alate adult morphs of Sitobion avenae (Fabricius). Morphs both continuously fed and starved aphids contained two telotrophic ovaries, each comprising five ovarioles. As time increase after emergence, the number of offspring produced by the fed aphids increased gradually, whereas the number of embryos in their ovaries decreased gradually. Both the number of mature embryos and the volume of embryos rapidly increased at 24 h after emergence, and then remained at an approximately constant level between 24 and 144 h. Compared to the fed aphids, starved aphids only produced a small number of nymphs, and there was no significant change in the total number of embryos between 24 and 144 h, whereas both the number of mature embryos and volume of embryos increased significantly. Irrespective of starvation period, highly significant relationships between life span and fecundity were found. Adult aphids starved for longer periods presented lower longevity and fecundity, but dead females contained more mature embryos than those starved for shorter periods. These results suggested that, under starvation stress, S. avenae tends to invest in the development of larger embryos at the expense of reducing lifespan and future fecundity. This adaptive reproductive strategy under starvation stress could be one of the factors contributing to the successful establishment of new colonies of alate migratory aphids.
Background
Neonicotinoid insecticides are applied worldwide for the control of agricultural insect pests. The evolution of neonicotinoid resistance has led to the failure of pest control in the field. The enhanced detoxifying enzyme activity and target mutations play important roles in the resistance of insects to neonicotinoid resistance. Emerging evidence indicates a central role of the gut symbiont in insect pest resistance to pesticides. Existing reports suggest that symbiotic microorganisms could mediate pesticide resistance by degrading pesticides in insect pests.
Results
The 16S rDNA sequencing results showed that the richness and diversity of the gut community between the imidacloprid-resistant (IMI-R) and imidacloprid-susceptible (IMI-S) strains of the cotton aphid Aphis gossypii showed no significant difference, while the abundance of the gut symbiont Sphingomonas was significantly higher in the IMI-R strain. Antibiotic treatment deprived Sphingomonas of the gut, followed by an increase in susceptibility to imidacloprid in the IMI-R strain. The susceptibility of the IMI-S strain to imidacloprid was significantly decreased as expected after supplementation with Sphingomonas. In addition, the imidacloprid susceptibility in nine field populations, which were all infected with Sphingomonas, increased to different degrees after treatment with antibiotics. Then, we demonstrated that Sphingomonas isolated from the gut of the IMI-R strain could subsist only with imidacloprid as a carbon source. The metabolic efficiency of imidacloprid by Sphingomonas reached 56% by HPLC detection. This further proved that Sphingomonas could mediate A. gossypii resistance to imidacloprid by hydroxylation and nitroreduction.
Conclusions
Our findings suggest that the gut symbiont Sphingomonas, with detoxification properties, could offer an opportunity for insect pests to metabolize imidacloprid. These findings enriched our knowledge of mechanisms of insecticide resistance and provided new symbiont-based strategies for control of insecticide-resistant insect pests with high Sphingomonas abundance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.